Skip to main navigation Skip to search Skip to main content

Synthesis and In Vitro/In silico Evaluation of Novel 2-Aryl-6-carboxamide-Substituted Benzoxazole Derivatives with Anticancer Effects and mTOR Inhibitory Potential

  • Ceylan Hepokur*
  • , Okan Aykaç
  • , Sema Misir
  • , Şeyda Akin
  • , Burak Kuzu
  • , Naveen Kosar
  • , Recep Kurnaz
  • , Öztekin Algül
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

In this study, we synthesized novel 2-aryl-6-carboxamide-substituted benzoxazole derivatives and evaluated their anticancer potential against breast cancer cell lines, with a focus on mTOR inhibitory activity. The compounds were synthesized via a three-step method and characterized by NMR analysis. In silico studies─including molecular docking, molecular dynamics simulations, and ADMET predictions─were conducted to predict interactions with the target protein and support the observed biological activity. IC50 values were determined in MCF-7 and MDA-MB-231 cells, with MCF-7 cells exhibiting greater sensitivity to the compound. The most active compounds, COH-17 and COH-19, demonstrated cytotoxicity as indicated by LDH release assays. Apoptotic effects were investigated at both molecular and cellular levels: Western blot analysis assessed key apoptotic proteins (Bcl-2, Bax, caspase-3, and p53), while RT-qPCR quantified the expression of BRCA1, BRCA2, PTEN, TP53, BCL-2, BAX, Caspase-3, PI3K, AKT, and BRAD1 genes. Morphological changes associated with apoptosis were confirmed by DAPI staining and fluorescence microscopy, and early and late apoptosis were quantified using Annexin V-FITC/PI flow cytometry. Cell cycle analysis revealed phase-specific arrest, further supporting the antiproliferative activity of the compound. Overall, COH-17 and COH-19 demonstrated potent anticancer effects through mTOR inhibition, induction of apoptosis, and cell cycle arrest, highlighting their potential as targeted therapeutic agents for breast cancer.

Original languageEnglish
Pages (from-to)32096-32117
Number of pages22
JournalACS Omega
Volume11
Issue number22
DOIs
StatePublished - 9 Jun 2026

Bibliographical note

Publisher Copyright:
© 2026 The Authors. Published by American Chemical Society.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Chemistry
  • General Chemical Engineering

Fingerprint

Dive into the research topics of 'Synthesis and In Vitro/In silico Evaluation of Novel 2-Aryl-6-carboxamide-Substituted Benzoxazole Derivatives with Anticancer Effects and mTOR Inhibitory Potential'. Together they form a unique fingerprint.

Cite this